Adam brings to the Center more than a decade of experience working at the FDA. Most recently, Adam was the deputy director of the FDA’s Office of Program and Strategic Analysis, which serves as an “internal consultancy” for FDA’s drug center, providing management consulting, policy analysis, process improvement, and advanced modeling and analytic methods to improve the center’s policy, decision-making, and operations. In this role, Adam managed analytical studies and major initiatives in a range of topics related to pharmaceutical regulation and drug safety, including studies on the impact of FDA’s drug labels on health outcomes and the use of innovative health IT solutions to address the opioid crisis.
Bachelor of Science in Policy Analysis and Management from Cornell University
Master’s in Public Policy and Management from Carnegie Mellon University